SPS
SLDB icon

Susquehanna Portfolio Strategies’s Solid Biosciences SLDB Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Sell
197,571
-1,865
-0.9% -$12K 0.02% 570
2025
Q4 		$1.12M Hold
199,436
– – 0.02% 624
2025
Q3 		$1.23M Hold
199,436
– – 0.02% 630
2025
Q2 		$971K Buy
199,436
+183,140
+1,124% +$647K 0.02% 511
2025
Q1 		$60.3K Buy
+16,296
New +$69.8K 0.03% 157

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Susquehanna Portfolio Strategies's SLDB Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Solid Biosciences (SLDB) stake by 0.94% in Q1 2026, selling an estimated $12K and leaving 197,571 shares worth $1.42M. The position accounts for 0.02% of the portfolio, ranked #570.

Susquehanna Portfolio Strategies first reported a position in SLDB in Q1 2025 and has held it in 5 quarters since. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Susquehanna Portfolio Strategies held 197,571 shares of Solid Biosciences worth $1.42M as of Q1 2026.
  • Susquehanna Portfolio Strategies sold 1,865 Solid Biosciences shares in Q1 2026, an estimated $12K.
  • Solid Biosciences made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #570 holding.
  • Susquehanna Portfolio Strategies first reported a position in Solid Biosciences in Q1 2025 and has held it in 5 quarters since.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.